Channelpedia

Kv1.5 Channel

769 automatically matched literature references

1

Wu W et al. Molecular Basis of Cardiac Delayed Rectifier Potassium Channel Function and Pharmacology.
Card Electrophysiol Clin, 2016 Jun , 8 (275-84).

2

Kojima A et al. Serum albumin attenuates the open-channel blocking effects of propofol on the human Kv1.5 channel.
Eur. J. Pharmacol., 2016 Jul 15 , 783 (117-26).

4

Lee HM et al. Blockade of Kv1.5 by paroxetine, an antidepressant drug.
Korean J. Physiol. Pharmacol., 2016 Jan , 20 (75-82).

7

Doczi MA et al. Developmental expression of Kv1 voltage-gated potassium channels in the avian hypothalamus.
Neurosci. Lett., 2016 Feb 1 , 616 (182-188).

8

Ou X et al. Myricetin inhibits Kv1.5 channels in HEK293 cells.
Mol Med Rep, 2016 Feb , 13 (1725-31).

9

Kajanus J et al. Isoindolinone compounds active as Kv1.5 blockers identified using a multicomponent reaction approach.
Bioorg. Med. Chem. Lett., 2016 Apr 15 , 26 (2023-9).

10

Ahmed M et al. SGK3 Sensitivity of Voltage Gated K+ Channel Kv1.5 (KCNA5).
Cell. Physiol. Biochem., 2016 , 38 (359-67).

12

Ohanyan V et al. Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation.
Circ. Res., 2015 Sep 11 , 117 (612-21).

13

Wang YY et al. [Effect of ERK1/2 on rat pulmonary artery smooth muscle cells Kv1.5 channel in the process of hypoxia].
Zhongguo Ying Yong Sheng Li Xue Za Zhi, 2015 Sep , 31 (418-21, 426).

14

Li P et al. E3 ligase CHIP and Hsc70 regulate Kv1.5 protein expression and function in mammalian cells.
J. Mol. Cell. Cardiol., 2015 Sep , 86 (138-46).

16

20

Lloyd J et al. Pseudosaccharin amines as potent and selective KV1.5 blockers.
Bioorg. Med. Chem. Lett., 2015 Mar 7 , ().

22

Yang L et al. Intravenous anesthetic propofol inhibits multiple human cardiac potassium channels.
Anesthesiology, 2015 Mar , 122 (571-84).

23

24

Warsi J et al. Regulation of Voltage-Gated K(+) Channel Kv1.5 by the Janus Kinase JAK3.
J. Membr. Biol., 2015 Jun 23 , ().

26

Yu J et al. Inhibitory effects of cortisone and hydrocortisone on human Kv1.5 channel currents.
Eur. J. Pharmacol., 2015 Jan 5 , 746 (158-66).

29

Chapalamadugu KC et al. High level of oxygen treatment causes cardiotoxicity with arrhythmias and redox modulation.
Toxicol. Appl. Pharmacol., 2015 Jan 1 , 282 (100-7).

30

Zheng L et al. Tanshinone IIA attenuates hypoxic pulmonary hypertension via modulating KV currents.
Respir Physiol Neurobiol, 2015 Jan 1 , 205 (120-8).

32

Männikkö R et al. Pharmacological and electrophysiological characterisation of hERG activator AZSMO-23.
Br. J. Pharmacol., 2015 Feb 12 , ().

33

Elvira B et al. SPAK and OSR1 sensitivity of voltage-gated K+ channel Kv1.5.
J. Membr. Biol., 2015 Feb , 248 (59-66).

38

Lee JY et al. The role of K⁺ conductances in regulating membrane excitability in human gastric corpus smooth muscle.
Am. J. Physiol. Gastrointest. Liver Physiol., 2015 Apr 1 , 308 (G625-33).

44

Bartok A et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels.
Toxicon, 2014 Sep , 87 (6-16).

45

Singhal R et al. Colchicine suppresses atrial fibrillation in failing heart.
Int. J. Cardiol., 2014 Oct 20 , 176 (651-60).

47

Carrisoza-Gaytán R et al. Differential expression of the Kv1 voltage-gated potassium channel family in the rat nephron.
J. Mol. Histol., 2014 Oct , 45 (583-97).

48

Frolov RV et al. Celecoxib and ion channels: a story of unexpected discoveries.
Eur. J. Pharmacol., 2014 May 5 , 730 (61-71).

49

Fischer F et al. Isoenzyme-specific regulation of cardiac Kv1.5/Kvβ1.2 ion channel complex by protein kinase C: central role of PKCβII.
Naunyn Schmiedebergs Arch. Pharmacol., 2014 May , 387 (469-76).

51

Olsson RI et al. Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channel.
Bioorg. Med. Chem. Lett., 2014 Mar 1 , 24 (1269-73).

55

Johnson JA et al. Design, synthesis and evaluation of phenethylaminoheterocycles as Kv1.5 inhibitors.
Bioorg. Med. Chem. Lett., 2014 Jul 15 , 24 (3018-22).

61

Ahmed M et al. Down-regulation of K⁺ channels by human parvovirus B19 capsid protein VP1.
Biochem. Biophys. Res. Commun., 2014 Aug 8 , 450 (1396-401).

62

Schmitt N et al. Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.
Physiol. Rev., 2014 Apr , 94 (609-53).

64

Dun W et al. SAP97 and cortactin remodeling in arrhythmogenic Purkinje cells.
PLoS ONE, 2014 , 9 (e106830).

70

Vonderlin N et al. Inhibition of cardiac Kv1.5 potassium current by the anesthetic midazolam: mode of action.
Drug Des Devel Ther, 2014 , 8 (2263-71).

73

Boycott HE et al. Shear stress triggers insertion of voltage-gated potassium channels from intracellular compartments in atrial myocytes.
Proc. Natl. Acad. Sci. U.S.A., 2013 Oct 8 , 110 (E3955-E3964).

76

Guo X et al. Design and bio-evaluation of indole derivatives as potent Kv1.5 inhibitors.
Bioorg. Med. Chem., 2013 Nov 1 , 21 (6466-76).

81

Finlay HJ et al. Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists.
Bioorg. Med. Chem. Lett., 2013 Mar 15 , 23 (1743-7).

82

84

Ravens U et al. Atrial selectivity of antiarrhythmic drugs.
J. Physiol. (Lond.), 2013 Jul 16 , ().

89

Olsson RI et al. Synthesis and evaluation of diphenylphosphinic amides and diphenylphosphine oxides as inhibitors of Kv1.5.
Bioorg. Med. Chem. Lett., 2013 Feb 1 , 23 (706-10).

90

Jeong I et al. Pergolide block of the cloned Kv1.5 potassium channels.
Naunyn Schmiedebergs Arch. Pharmacol., 2013 Feb , 386 (125-33).

91

Tikhonov DB et al. Homology modeling of Kv1.5 channel block by cationic and electroneutral ligands.
Biochim. Biophys. Acta, 2013 Dec 5 , 1838 (978-987).

94

Wulff H et al. Channels: Sticking to nooks and crannies.
Nat. Chem. Biol., 2013 Aug , 9 (473-4).

98

102

Mia S et al. Downregulation of Kv1.5 K Channels by the AMP-Activated Protein Kinase.
Cell. Physiol. Biochem., 2012 Sep 24 , 30 (1039-1050).

105

Barber AF et al. Novel activation of voltage-gated K(+) channels by sevoflurane.
J. Biol. Chem., 2012 Nov 23 , 287 (40425-32).

106

Wang T et al. Trafficking of an endogenous potassium channel in adult ventricular myocytes.
Am. J. Physiol., Cell Physiol., 2012 Nov 1 , 303 (C963-76).

108

Birner C et al. Differential expression of potassium channels and abnormal conduction in experimental tachycardia-induced heart failure.
Naunyn Schmiedebergs Arch. Pharmacol., 2012 May , 385 (473-80).

113

Gönczi M et al. Age-dependent changes in ion channel mRNA expression in canine cardiac tissues.
Gen. Physiol. Biophys., 2012 Jun , 31 (153-62).

115

Kulzer M et al. Inhibition of cardiac Kir2.1-2.3 channels by beta3 adrenoreceptor antagonist SR 59230A.
Biochem. Biophys. Res. Commun., 2012 Jul 27 , 424 (315-20).

119

Jeong I et al. Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells.
Naunyn Schmiedebergs Arch. Pharmacol., 2012 Jul , 385 (707-16).

120

Munoz C et al. Activation of voltage gated K⁺ channel Kv1.5 by β-catenin.
Biochem. Biophys. Res. Commun., 2012 Jan 13 , 417 (692-6).

122

Jeong I et al. Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.
Biochem. Pharmacol., 2012 Feb 15 , 83 (497-505).

125

Suzuki S et al. Stabilization of Kv1.5 channel protein by bepridil through its action as a chemical chaperone.
Eur. J. Pharmacol., 2012 Dec 5 , 696 (28-34).

126

Schweikart K et al. The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity.
Toxicol In Vitro, 2012 Dec 20 , 27 (745-751).

127

Ishii K et al. Endocytic regulation of voltage-dependent potassium channels in the heart.
J. Pharmacol. Sci., 2012 Dec 18 , 120 (264-9).

131

Liu Y et al. Effects of the natural flavone trimethylapigenin on cardiac potassium currents.
Biochem. Pharmacol., 2012 Aug 15 , 84 (498-506).

137

Moreno C et al. Polyunsaturated Fatty acids modify the gating of kv channels.
Front Pharmacol, 2012 , 3 (163).

139

140

Leanza L et al. Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels.
Curr. Med. Chem., 2012 , 19 (5394-404).

142

144

146

Parvez B et al. The "missing" link in atrial fibrillation heritability.
J Electrocardiol, 2011 Nov , 44 (641-4).

150

Hu H et al. [Effects of ethanol on action potential of rat myocardium and human Kv1.5 channel].
Sheng Li Xue Bao, 2011 Jun 25 , 63 (219-24).

156

Zhu S et al. Molecular diversity and functional evolution of scorpion potassium channel toxins.
Mol. Cell Proteomics, 2011 Feb , 10 (M110.002832).

158

159

162

El Gebeily G et al. Upregulation of ventricular potassium channels by chronic tamoxifen treatment.
Cardiovasc. Res., 2011 Apr 1 , 90 (68-76).

163

Mogensen C et al. Isolation and functional characterization of pericytes derived from hamster skeletal muscle.
Acta Physiol (Oxf), 2011 Apr , 201 (413-26).

165

Moral-Sanz J et al. Pulmonary arterial dysfunction in insulin resistant obese Zucker rats.
Respir. Res., 2011 , 12 (51).

167

Zhong XZ et al. Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter.
J. Physiol. (Lond.), 2010 Sep 1 , 588 (3277-93).

169

172

Jeong I et al. Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.
Pflugers Arch., 2010 Oct , 460 (851-62).

173

Almquist J et al. Modeling the effect of kv1.5 block on the canine action potential.
Biophys. J., 2010 Nov 3 , 99 (2726-36).

174

182

Rangaraju S et al. Potassium channel modulation by a toxin domain in matrix metalloprotease 23.
J. Biol. Chem., 2010 Mar 19 , 285 (9124-36).

184

185

Burg ED et al. Tetramerization domain mutations in KCNA5 affect channel kinetics and cause abnormal trafficking patterns.
Am. J. Physiol., Cell Physiol., 2010 Mar , 298 (C496-509).

189

Gonzalez T et al. Kv1.5-Kv beta interactions: molecular determinants and pharmacological consequences.
Mini Rev Med Chem, 2010 Jun , 10 (635-42).

196

Lloyd J et al. Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockers.
Bioorg. Med. Chem. Lett., 2010 Feb 15 , 20 (1436-9).

198

Haim TE et al. Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currents.
J. Mol. Cell. Cardiol., 2010 Feb , 48 (395-405).

201

202

Li Y et al. Aconitine blocks HERG and Kv1.5 potassium channels.
, 2010 Aug 19 , 131 (187-195).

207

208

Beshore DC et al. Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel.
Bioorg. Med. Chem. Lett., 2010 Apr 15 , 20 (2493-6).

209

Lee HM et al. Open channel block of Kv1.5 currents by citalopram.
Acta Pharmacol. Sin., 2010 Apr , 31 (429-35).

211

Bielanska J et al. Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human fetus.
Cell. Physiol. Biochem., 2010 , 26 (219-26).

212

Lee HM et al. Inhibitory action of fluvoxamine on Kv1.5 currents.
Biol. Pharm. Bull., 2010 , 33 (977-82).

213

Antzelevitch C et al. Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
J Electrocardiol, 2009 Nov-Dec , 42 (543-8).

217

Zadeh AD et al. Kif5b is an essential forward trafficking motor for the Kv1.5 cardiac potassium channel.
J. Physiol. (Lond.), 2009 Oct 1 , 587 (4565-74).

220

Firth AL et al. Hypoxia selectively inhibits KCNA5 channels in pulmonary artery smooth muscle cells.
Ann. N. Y. Acad. Sci., 2009 Oct , 1177 (101-11).

222

Yang Y et al. Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation.
J. Hum. Genet., 2009 May , 54 (277-83).

223

Chen J et al. PKA phosphorylation of HERG protein regulates the rate of channel synthesis.
Am. J. Physiol. Heart Circ. Physiol., 2009 May , 296 (H1244-54).

224

Ureche ON et al. Differential modulation of cardiac potassium channels by Grb adaptor proteins.
Biochem. Biophys. Res. Commun., 2009 Jun 19 , 384 (28-31).

225

Schumacher SM et al. Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.
Circ. Res., 2009 Jun 19 , 104 (1390-8).

226

Gross MF et al. Aryl sulfonamido tetralin inhibitors of the Kv1.5 ion channel.
Bioorg. Med. Chem. Lett., 2009 Jun 1 , 19 (3063-6).

227

Sridhar A et al. Chronic heart failure and the substrate for atrial fibrillation.
Cardiovasc. Res., 2009 Jul 17 , ().

229

Karczewski J et al. High-throughput analysis of drug binding interactions for the human cardiac channel, Kv1.5.
Biochem. Pharmacol., 2009 Jan 15 , 77 (177-85).

230

Chu X et al. Hypoxia suppresses KV1.5 channel expression through endogenous 15-HETE in rat pulmonary artery.
Prostaglandins Other Lipid Mediat., 2009 Jan , 88 (42-50).

232

Koshida S et al. Stabilizing effects of eicosapentaenoic acid on Kv1.5 channel protein expressed in mammalian cells.
Eur. J. Pharmacol., 2009 Feb 14 , 604 (93-102).

234

Yang L et al. Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment.
Clin. Exp. Pharmacol. Physiol., 2009 Feb , 36 (154-61).

235

Li MW et al. [Effects of telmisartan on voltage-gated Kv1.3 and Kv1.5 potassium channels expressed in Xenopus oocytes]
Zhonghua Xin Xue Guan Bing Za Zhi, 2009 Feb , 37 (165-8).

236

238

Bielanska J et al. Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer.
Curr Cancer Drug Targets, 2009 Dec , 9 (904-14).

240

Saito T et al. Estrogen contributes to gender differences in mouse ventricular repolarization.
Circ. Res., 2009 Aug 14 , 105 (343-52).

243

244

246

Yang Q et al. Drug discoveries towards Kv1.5 potassium channel.
, 2009 , 9 (339-47).

248

Cutz E et al. The role of NOX2 and "novel oxidases" in airway chemoreceptor O(2) sensing.
Adv. Exp. Med. Biol., 2009 , 648 (427-38).

249

Xuan NT et al. Ca2+-dependent functions in peptidoglycan-stimulated mouse dendritic cells.
Cell. Physiol. Biochem., 2009 , 24 (167-76).

252

Yang Q et al. Modeling the binding modes of Kv1.5 potassium channel and blockers.
J. Mol. Graph. Model., 2008 Sep , 27 (178-87).

253

Lvov A et al. VAMP2 interacts directly with the N terminus of Kv2.1 to enhance channel inactivation.
Pflugers Arch., 2008 Sep , 456 (1121-36).

254

Burashnikov A et al. Can inhibition of IKur promote atrial fibrillation?
, 2008 Sep , 5 (1304-9).

255

Aréchiga IA et al. Kv1.5 open channel block by the antiarrhythmic drug disopyramide: molecular determinants of block.
J. Pharmacol. Sci., 2008 Sep , 108 (49-55).

256

Zadeh AD et al. Internalized Kv1.5 traffics via Rab-dependent pathways.
J. Physiol. (Lond.), 2008 Oct 15 , 586 (4793-813).

259

Matzner N et al. Ion channels modulating mouse dendritic cell functions.
J. Immunol., 2008 Nov 15 , 181 (6803-9).

261

Villalonga N et al. Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation.
Biochim. Biophys. Acta, 2008 May , 1783 (728-36).

263

Johnson JN et al. Prevalence of early-onset atrial fibrillation in congenital long QT syndrome.
Heart Rhythm, 2008 May , 5 (704-9).

264

Vicente R et al. Kv1.5 association modifies Kv1.3 traffic and membrane localization.
J. Biol. Chem., 2008 Mar 28 , 283 (8756-64).

265

McEwen DP et al. Caveolin regulates kv1.5 trafficking to cholesterol-rich membrane microdomains.
Mol. Pharmacol., 2008 Mar , 73 (678-85).

266

269

Yang Z et al. Four and a half LIM protein 1: a partner for KCNA5 in human atrium.
Cardiovasc. Res., 2008 Jun 1 , 78 (449-57).

270

Liu GX et al. Single-channel properties of I K,slow1 and I K,slow2 in mouse ventricular myocytes.
Pflugers Arch., 2008 Jun , 456 (541-7).

271

Labro AJ et al. A Kv channel with an altered activation gate sequence displays both "fast" and "slow" activation kinetics.
Am. J. Physiol., Cell Physiol., 2008 Jun , 294 (C1476-84).

272

Wong JY et al. Dichloroacetate induces apoptosis in endometrial cancer cells.
Gynecol. Oncol., 2008 Jun , 109 (394-402).

275

Salom JB et al. Role of K+ and Ca2+ fluxes in the cerebroarterial vasoactive effects of sildenafil.
Eur. J. Pharmacol., 2008 Feb 26 , 581 (138-47).

284

Martínez-Mármol R et al. Multiple Kv1.5 targeting to membrane surface microdomains.
J. Cell. Physiol., 2008 Dec , 217 (667-73).

287

Cui JX et al. [Study on the roles of voltaged potassium channels in acute hypoxic pulmonary vasoconstriction]
Nan Fang Yi Ke Da Xue Xue Bao, 2008 Dec , 28 (2200-1).

288

Sun DD et al. Tanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels.
Eur. J. Pharmacol., 2008 Aug 20 , 590 (317-21).

289

Hirota Y et al. Functional stabilization of Kv1.5 protein by Hsp70 in mammalian cell lines.
Biochem. Biophys. Res. Commun., 2008 Aug 1 , 372 (469-74).

295

Abi-Char J et al. The anchoring protein SAP97 retains Kv1.5 channels in the plasma membrane of cardiac myocytes.
Am. J. Physiol. Heart Circ. Physiol., 2008 Apr , 294 (H1851-61).

298

Li HY et al. Eugenol inhibits K+ currents in trigeminal ganglion neurons.
J. Dent. Res., 2007 Sep , 86 (898-902).

299

McEwen DP et al. Rab-GTPase-dependent endocytic recycling of Kv1.5 in atrial myocytes.
J. Biol. Chem., 2007 Oct 5 , 282 (29612-20).

300

Arias C et al. Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
Anesthesiology, 2007 Oct , 107 (641-51).

301

Koutsouki E et al. Modulation of human Kv1.5 channel kinetics by N-cadherin.
Biochem. Biophys. Res. Commun., 2007 Nov 9 , 363 (18-23).

302

Fountain SJ et al. K(v)1.5 potassium channel gene regulation by Sp1 transcription factor and oxidative stress.
Am. J. Physiol. Heart Circ. Physiol., 2007 Nov , 293 (H2719-25).

303

Bai X et al. Electrophysiological properties of human adipose tissue-derived stem cells.
Am. J. Physiol., Cell Physiol., 2007 Nov , 293 (C1539-50).

306

Gross MF et al. Aryl sulfonamido indane inhibitors of the Kv1.5 ion channel.
Bioorg. Med. Chem. Lett., 2007 May 15 , 17 (2849-53).

307

Remillard CV et al. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.
Am. J. Physiol., Cell Physiol., 2007 May , 292 (C1837-53).

308

Vaquero M et al. Effects of atorvastatin and simvastatin on atrial plateau currents.
J. Mol. Cell. Cardiol., 2007 May , 42 (931-45).

309

Martínez-Gómez A et al. Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve.
Neuroreport, 2007 Mar 26 , 18 (447-50).

310

Nielsen NH et al. Mutations in the Kv1.5 channel gene KCNA5 in cardiac arrest patients.
Biochem. Biophys. Res. Commun., 2007 Mar 16 , 354 (776-82).

311

Eduljee C et al. SCAM analysis reveals a discrete region of the pore turret that modulates slow inactivation in Kv1.5.
Am. J. Physiol., Cell Physiol., 2007 Mar , 292 (C1041-52).

313

Lloyd J et al. Benzopyran sulfonamides as KV1.5 potassium channel blockers.
Bioorg. Med. Chem. Lett., 2007 Jun 15 , 17 (3271-5).

314

Bonnet S et al. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
Proc. Natl. Acad. Sci. U.S.A., 2007 Jul 3 , 104 (11418-23).

315

Tipparaju SM et al. NADPH binding to beta-subunit regulates inactivation of voltage-gated K(+) channels.
Biochem. Biophys. Res. Commun., 2007 Jul 27 , 359 (269-76).

316

317

Zhang L et al. S-acylation regulates Kv1.5 channel surface expression.
Am. J. Physiol., Cell Physiol., 2007 Jul , 293 (C152-61).

319

Ehrlich JR et al. Novel anti-arrhythmic drugs for atrial fibrillation management.
, 2007 Jul , 5 (185-95).

320

Villalonga N et al. Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages.
Biochem. Biophys. Res. Commun., 2007 Jan 26 , 352 (913-8).

321

Jackson CM et al. Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias.
Bioorg. Med. Chem. Lett., 2007 Jan 1 , 17 (282-4).

322

Gautier M et al. Heterogeneous Kv1 function and expression in coronary myocytes from right and left ventricles in rats.
Am. J. Physiol. Heart Circ. Physiol., 2007 Jan , 292 (H475-82).

325

Benson MD et al. SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5.
Proc. Natl. Acad. Sci. U.S.A., 2007 Feb 6 , 104 (1805-10).

326

Ousingsawat J et al. Expression of voltage-gated potassium channels in human and mouse colonic carcinoma.
Clin. Cancer Res., 2007 Feb 1 , 13 (824-31).

327

McGahon MK et al. Kv1.5 is a major component underlying the A-type potassium current in retinal arteriolar smooth muscle.
Am. J. Physiol. Heart Circ. Physiol., 2007 Feb , 292 (H1001-8).

328

Eun JS et al. Synthesis of psoralen derivatives and their blocking effect of hKv1.5 channel.
Arch. Pharm. Res., 2007 Feb , 30 (155-60).

330

Rezazadeh S et al. An activation gating switch in Kv1.2 is localized to a threonine residue in the S2-S3 linker.
Biophys. J., 2007 Dec 15 , 93 (4173-86).

333

Abi-Char J et al. Membrane cholesterol modulates Kv1.5 potassium channel distribution and function in rat cardiomyocytes.
J. Physiol. (Lond.), 2007 Aug 1 , 582 (1205-17).

334

Platoshyn O et al. Heterogeneity of hypoxia-mediated decrease in I(K(V)) and increase in [Ca2+](cyt) in pulmonary artery smooth muscle cells.
Am. J. Physiol. Lung Cell Mol. Physiol., 2007 Aug , 293 (L402-16).

335

Wirth KJ et al. In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231.
J. Cardiovasc. Pharmacol., 2007 Apr , 49 (197-206).

339

340

Decher N et al. Binding site of a novel Kv1.5 blocker: a "foot in the door" against atrial fibrillation.
Mol. Pharmacol., 2006 Oct , 70 (1204-11).

341

Kwak YG et al. Torilin from Torilis japonica (Houtt.) DC. blocks hKv1.5 channel current.
Arch. Pharm. Res., 2006 Oct , 29 (834-9).

343

Wu S et al. Discovery and synthesis of tetrahydroindolone derived semicarbazones as selective Kv1.5 blockers.
Bioorg. Med. Chem. Lett., 2006 Nov 15 , 16 (5859-63).

344

Fluxe A et al. Discovery and synthesis of tetrahydroindolone-derived carbamates as Kv1.5 blockers.
Bioorg. Med. Chem. Lett., 2006 Nov 15 , 16 (5855-8).

346

Eldstrom J et al. Localization of Kv1.5 channels in rat and canine myocyte sarcolemma.
FEBS Lett., 2006 Nov 13 , 580 (6039-46).

347

Abdel-Mottaleb Y et al. The first potassium channel toxin from the venom of the Iranian scorpion Odonthobuthus doriae.
FEBS Lett., 2006 Nov 13 , 580 (6254-8).

349

Salvador-Recatalà V et al. Voltage-gated k+ channel block by catechol derivatives: defining nonselective and selective pharmacophores.
J. Pharmacol. Exp. Ther., 2006 Nov , 319 (758-64).

350

352

Mathur R et al. A specific N-terminal residue in Kv1.5 is required for upregulation of the channel by SAP97.
Biochem. Biophys. Res. Commun., 2006 Mar 31 , 342 (1-8).

353

Maguy A et al. Involvement of lipid rafts and caveolae in cardiac ion channel function.
Cardiovasc. Res., 2006 Mar 1 , 69 (798-807).

354

Platoshyn O et al. Acute hypoxia selectively inhibits KCNA5 channels in pulmonary artery smooth muscle cells.
Am. J. Physiol., Cell Physiol., 2006 Mar , 290 (C907-16).

359

Chen TT et al. Key role of Kv1 channels in vasoregulation.
Circ. Res., 2006 Jul 7 , 99 (53-60).

360

Park SA et al. hKv1.5 channels play a pivotal role in the functions of human alveolar macrophages.
Biochem. Biophys. Res. Commun., 2006 Jul 28 , 346 (567-71).

361

Olson TM et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation.
Hum. Mol. Genet., 2006 Jul 15 , 15 (2185-91).

366

367

Wu S et al. Discovery and in vitro/in vivo studies of tetrazole derivatives as Kv1.5 blockers.
Bioorg. Med. Chem. Lett., 2006 Dec 15 , 16 (6213-8).

368

Claydon TW et al. Block by internal Mg2+ causes voltage-dependent inactivation of Kv1.5.
Eur. Biophys. J., 2006 Dec , 36 (23-34).

369

Pannasch U et al. The potassium channels Kv1.5 and Kv1.3 modulate distinct functions of microglia.
Mol. Cell. Neurosci., 2006 Dec , 33 (401-11).

372

Ordög B et al. Gene expression profiling of human cardiac potassium and sodium channels.
Int. J. Cardiol., 2006 Aug 28 , 111 (386-93).

382

Dhoke MA et al. Porous membranes for reconstitution of ion channels.
Biochim. Biophys. Acta, 2005 Oct 15 , 1716 (117-25).

383

Kurata HT et al. Separation of P/C- and U-type inactivation pathways in Kv1.5 potassium channels.
J. Physiol. (Lond.), 2005 Oct 1 , 568 (31-46).

384

Hu Y et al. Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria.
Am. J. Physiol. Heart Circ. Physiol., 2005 Oct , 289 (H1448-55).

385

Liu L et al. Expression and characterization of delayed rectifying K+ channels in anterior rat taste buds.
Am. J. Physiol., Cell Physiol., 2005 Oct , 289 (C868-80).

387

Kato M et al. Evidence for proteasomal degradation of Kv1.5 channel protein.
Biochem. Biophys. Res. Commun., 2005 Nov 11 , 337 (343-8).

388

Barfield JP et al. The effects of putative K+ channel blockers on volume regulation of murine spermatozoa.
Biol. Reprod., 2005 May , 72 (1275-81).

389

Simard C et al. Polymorphism screening in the cardiac K+ channel gene KCNA5.
Clin. Pharmacol. Ther., 2005 Mar , 77 (138-44).

390

Eun JS et al. Open channel block of hKv1.5 by psoralen from Heracleum moellendorffii Hance.
Arch. Pharm. Res., 2005 Mar , 28 (269-73).

392

Wang J et al. Chronic hypoxia inhibits Kv channel gene expression in rat distal pulmonary artery.
Am. J. Physiol. Lung Cell Mol. Physiol., 2005 Jun , 288 (L1049-58).

393

Hotchkiss K et al. Ion channel proteins in mouse and human vestibular tissue.
, 2005 Jun , 132 (916-23).

395

Li H et al. KChIP2 modulates the cell surface expression of Kv 1.5-encoded K(+) channels.
J. Mol. Cell. Cardiol., 2005 Jul , 39 (121-32).

399

Brouillette J et al. Sex and strain differences in adult mouse cardiac repolarization: importance of androgens.
Cardiovasc. Res., 2005 Jan 1 , 65 (148-57).

400

Kuryshev YA et al. Pentamidine-induced long QT syndrome and block of hERG trafficking.
J. Pharmacol. Exp. Ther., 2005 Jan , 312 (316-23).

402

Plane F et al. Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter.
Circ. Res., 2005 Feb 4 , 96 (216-24).

404

Tammaro P et al. Effects of intracellular magnesium on Kv1.5 and Kv2.1 potassium channels.
Eur. Biophys. J., 2005 Feb , 34 (42-51).

407

Barfield JP et al. Characterization of potassium channels involved in volume regulation of human spermatozoa.
Mol. Hum. Reprod., 2005 Dec , 11 (891-7).

408

Fordyce CB et al. Microglia Kv1.3 channels contribute to their ability to kill neurons.
J. Neurosci., 2005 Aug 3 , 25 (7139-49).

410

Choi BH et al. Direct block of cloned hKv1.5 channel by cytochalasins, actin-disrupting agents.
Am. J. Physiol., Cell Physiol., 2005 Aug , 289 (C425-36).

413

Eun JS et al. Effects of oxypeucedanin on hKv1.5 and action potential duration.
Biol. Pharm. Bull., 2005 Apr , 28 (657-60).

414

421

Brevnova EE et al. Overexpression of human KCNA5 increases IK V and enhances apoptosis.
Am. J. Physiol., Cell Physiol., 2004 Sep , 287 (C715-22).

423

Gögelein H et al. Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels.
Naunyn Schmiedebergs Arch. Pharmacol., 2004 Sep , 370 (183-92).

428

Zhang HX et al. Galantamine blocks cloned Kv2.1, but not Kv1.5 potassium channels.
Brain Res. Mol. Brain Res., 2004 Nov 24 , 131 (136-40).

430

Rossow CF et al. NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction.
Circ. Res., 2004 May 28 , 94 (1340-50).

431

Kurata HT et al. NH2-terminal inactivation peptide binding to C-type-inactivated Kv channels.
J. Gen. Physiol., 2004 May , 123 (505-20).

433

Ferber M et al. Identification of a mammalian target of kappaM-conotoxin RIIIK.
Toxicon, 2004 Jun 15 , 43 (915-21).

435

Vennekamp J et al. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
Mol. Pharmacol., 2004 Jun , 65 (1364-74).

439

Li H et al. Selective elimination of I(K,slow1) in mouse ventricular myocytes expressing a dominant negative Kv1.5alpha subunit.
Am. J. Physiol. Heart Circ. Physiol., 2004 Jan , 286 (H319-28).

440

Godreau D et al. [MAGUKs: beyond ionic channel anchoring]
Med Sci (Paris), 2004 Jan , 20 (84-8).

441

Duzhyy DE et al. Cloning and developmental expression of Shaker potassium channels in the cochlea of the chicken.
Brain Res. Mol. Brain Res., 2004 Feb 5 , 121 (70-85).

442

Caballero R et al. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
Cardiovasc. Res., 2004 Dec 1 , 64 (457-66).

445

Brunet S et al. Heterogeneous expression of repolarizing, voltage-gated K+ currents in adult mouse ventricles.
J. Physiol. (Lond.), 2004 Aug 15 , 559 (103-20).

447

Folco EJ et al. Caveolin-3 and SAP97 form a scaffolding protein complex that regulates the voltage-gated potassium channel Kv1.5.
Am. J. Physiol. Heart Circ. Physiol., 2004 Aug , 287 (H681-90).

451

Grunnet M et al. KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels.
Biophys. J., 2003 Sep , 85 (1525-37).

452

Fedida D et al. Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes.
Circ. Res., 2003 Oct 17 , 93 (744-51).

453

Brendel J et al. Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias.
Curr Med Chem Cardiovasc Hematol Agents, 2003 Oct , 1 (273-87).

454

459

Preussat K et al. Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas.
Neurosci. Lett., 2003 Jul 31 , 346 (33-6).

460

Eldstrom J et al. SAP97 increases Kv1.5 currents through an indirect N-terminal mechanism.
FEBS Lett., 2003 Jul 17 , 547 (205-11).

461

Brunner M et al. In vivo gene transfer of Kv1.5 normalizes action potential duration and shortens QT interval in mice with long QT phenotype.
Am. J. Physiol. Heart Circ. Physiol., 2003 Jul , 285 (H194-203).

462

Brouillette J et al. Effect of androgen deficiency on mouse ventricular repolarization.
J. Physiol. (Lond.), 2003 Jan 15 , 546 (403-13).

463

Soliven B et al. PDGF upregulates delayed rectifier via Src family kinases and sphingosine kinase in oligodendroglial progenitors.
Am. J. Physiol., Cell Physiol., 2003 Jan , 284 (C85-93).

464

Trapani JG et al. Effect of external pH on activation of the Kv1.5 potassium channel.
Biophys. J., 2003 Jan , 84 (195-204).

469

Choe H et al. Papaverine blocks hKv1.5 channel current and human atrial ultrarapid delayed rectifier K+ currents.
J. Pharmacol. Exp. Ther., 2003 Feb , 304 (706-12).

470

Moreno I et al. Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
J. Pharmacol. Exp. Ther., 2003 Feb , 304 (862-73).

473

Bru-Mercier G et al. Expression of heart K+ channels in adrenalectomized and catecholamine-depleted reserpine-treated rats.
J. Mol. Cell. Cardiol., 2003 Feb , 35 (153-63).

474

Caouette D et al. Hydrogen peroxide modulates the Kv1.5 channel expressed in a mammalian cell line.
Naunyn Schmiedebergs Arch. Pharmacol., 2003 Dec , 368 (479-86).

475

Watanabe H et al. Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium.
Biochem. Biophys. Res. Commun., 2003 Aug 29 , 308 (439-44).

478

Yamashita T et al. Circadian variation of cardiac K+ channel gene expression.
Circulation, 2003 Apr 15 , 107 (1917-22).

481

482

Caballero R et al. Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5).
Cardiovasc. Res., 2002 Oct , 56 (104-17).

483

Eldstrom J et al. N-terminal PDZ-binding domain in Kv1 potassium channels.
FEBS Lett., 2002 Nov 20 , 531 (529-37).

485

Bertaso F et al. Expression of voltage-gated K+ channels in human atrium.
Basic Res. Cardiol., 2002 Nov , 97 (424-33).

488

Choi BH et al. Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor.
Am. J. Physiol., Cell Physiol., 2002 Jun , 282 (C1461-8).

489

Drici MD et al. Mice display sex differences in halothane-induced polymorphic ventricular tachycardia.
Circulation, 2002 Jul 23 , 106 (497-503).

490

Thorne GD et al. Hypoxic vasorelaxation inhibition by organ culture correlates with loss of Kv channels but not Ca(2+) channels.
Am. J. Physiol. Heart Circ. Physiol., 2002 Jul , 283 (H247-53).

491

493

Rich TC et al. Mutations throughout the S6 region of the hKv1.5 channel alter the stability of the activation gate.
Am. J. Physiol., Cell Physiol., 2002 Jan , 282 (C161-71).

494

Mason DE et al. Molecular basis of voltage-dependent potassium currents in porcine granulosa cells.
Mol. Pharmacol., 2002 Jan , 61 (201-13).

500

Fearon IM et al. O2-sensitive K+ channels in immortalised rat chromaffin-cell-derived MAH cells.
J. Physiol. (Lond.), 2002 Dec 15 , 545 (807-18).

501

Gonzalez T et al. Assembly with the Kvbeta1.3 subunit modulates drug block of hKv1.5 channels.
Mol. Pharmacol., 2002 Dec , 62 (1456-63).

502

Godreau D et al. Expression, regulation and role of the MAGUK protein SAP-97 in human atrial myocardium.
Cardiovasc. Res., 2002 Dec , 56 (433-42).

503

Kurata HT et al. Amino-terminal determinants of U-type inactivation of voltage-gated K+ channels.
J. Biol. Chem., 2002 Aug 9 , 277 (29045-53).

505

Williams CP et al. Modulation of the human Kv1.5 channel by protein kinase C activation: role of the Kvbeta1.2 subunit.
J. Pharmacol. Exp. Ther., 2002 Aug , 302 (545-50).

509

Aydar E et al. The sigma receptor as a ligand-regulated auxiliary potassium channel subunit.
Neuron, 2002 Apr 25 , 34 (399-410).

510

511

Petrashevskaya NN et al. Cardiac function and electrical remodeling of the calcineurin-overexpressed transgenic mouse.
Cardiovasc. Res., 2002 Apr , 54 (117-32).

513

516

Perchenet L et al. External nickel blocks human Kv1.5 channels stably expressed in CHO cells.
J. Membr. Biol., 2001 Sep 1 , 183 (51-60).

518

Perchenet L et al. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
J. Pharmacol. Exp. Ther., 2001 Sep , 298 (1108-19).

519

Kurata HT et al. Altered state dependence of c-type inactivation in the long and short forms of human Kv1.5.
J. Gen. Physiol., 2001 Sep , 118 (315-32).

520

Longobardo M et al. Bupivacaine effects on hKv1.5 channels are dependent on extracellular pH.
Br. J. Pharmacol., 2001 Sep , 134 (359-69).

521

Michelakis ED et al. The pathobiology of pulmonary hypertension. Smooth muscle cells and ion channels.
Clin. Chest Med., 2001 Sep , 22 (419-32).

522

Horio Y Potassium channels of glial cells: distribution and function.
Jpn. J. Pharmacol., 2001 Sep , 87 (1-6).

524

McKay MC et al. Linoleic acid both enhances activation and blocks Kv1.5 and Kv2.1 channels by two separate mechanisms.
Am. J. Physiol., Cell Physiol., 2001 Oct , 281 (C1277-84).

527

Kobayashi S et al. Inhibitory effect of bepridil on hKv1.5 channel current: comparison with amiodarone and E-4031.
Eur. J. Pharmacol., 2001 Nov 2 , 430 (149-57).

531

Li H et al. Functional expression of a GFP-tagged Kv1.5 alpha-subunit in mouse ventricle.
Am. J. Physiol. Heart Circ. Physiol., 2001 Nov , 281 (H1955-67).

533

Bachmann A et al. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
Naunyn Schmiedebergs Arch. Pharmacol., 2001 Nov , 364 (472-8).

542

Lin S et al. Influence of permeating ions on Kv1.5 channel block by nifedipine.
Am. J. Physiol. Heart Circ. Physiol., 2001 Mar , 280 (H1160-72).

546

Reeve HL et al. Alterations in a redox oxygen sensing mechanism in chronic hypoxia.
J. Appl. Physiol., 2001 Jun , 90 (2249-56).

547

Ekhterae D et al. Bcl-2 decreases voltage-gated K+ channel activity and enhances survival in vascular smooth muscle cells.
Am. J. Physiol., Cell Physiol., 2001 Jul , 281 (C157-65).

548

Kuryshev YA et al. KChAP/Kvbeta1.2 interactions and their effects on cardiac Kv channel expression.
Am. J. Physiol., Cell Physiol., 2001 Jul , 281 (C290-9).

549

Coppock EA et al. Molecular basis of hypoxia-induced pulmonary vasoconstriction: role of voltage-gated K+ channels.
Am. J. Physiol. Lung Cell Mol. Physiol., 2001 Jul , 281 (L1-12).

550

Zhang S et al. Modulation of Kv1.5 potassium channel gating by extracellular zinc.
Biophys. J., 2001 Jul , 81 (125-36).

551

Patel AJ et al. Molecular physiology of oxygen-sensitive potassium channels.
Eur. Respir. J., 2001 Jul , 18 (221-7).

556

González T et al. Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels.
J. Pharmacol. Exp. Ther., 2001 Feb , 296 (573-83).

558

Murata M et al. SAP97 interacts with Kv1.5 in heterologous expression systems.
Am. J. Physiol. Heart Circ. Physiol., 2001 Dec , 281 (H2575-84).

559

Coppock EA et al. Differential expression of K(V) channel alpha- and beta-subunits in the bovine pulmonary arterial circulation.
Am. J. Physiol. Lung Cell Mol. Physiol., 2001 Dec , 281 (L1350-60).

560

Trépanier-Boulay V et al. Gender-based differences in cardiac repolarization in mouse ventricle.
Circ. Res., 2001 Aug 31 , 89 (437-44).

563

Andrews EM et al. Voltage-gated K+ channels in chemoreceptor sensory neurons of rat petrosal ganglion.
Brain Res., 2001 Apr 6 , 897 (199-203).

565

Platoshyn O et al. Chronic hypoxia decreases K(V) channel expression and function in pulmonary artery myocytes.
Am. J. Physiol. Lung Cell Mol. Physiol., 2001 Apr , 280 (L801-12).

566

Khanna R et al. K+ channels and the microglial respiratory burst.
Am. J. Physiol., Cell Physiol., 2001 Apr , 280 (C796-806).

568

Fernandez M et al. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder.
Ann. Neurol., 2001 Apr , 49 (486-92).

570

Davies AR et al. Kv channel subunit expression in rat pulmonary arteries.
Lung, 2001 , 179 (147-61).

572

573

Braun AP et al. Inhibition of a mammalian large conductance, calcium-sensitive K+ channel by calmodulin-binding peptides.
J. Physiol. (Lond.), 2000 Sep 15 , 527 Pt 3 (479-92).

576

Perchenet L et al. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
J. Pharmacol. Exp. Ther., 2000 Nov , 295 (771-8).

580

Choi BH et al. Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells.
J. Pharmacol. Exp. Ther., 2000 May , 293 (634-40).

581

Longobardo M et al. Effects of a quaternary bupivacaine derivative on delayed rectifier K(+) currents.
Br. J. Pharmacol., 2000 May , 130 (391-401).

582

Kang J et al. High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide.
Eur. J. Pharmacol., 2000 Mar 31 , 392 (137-40).

583

Osipenko ON et al. Potential role for kv3.1b channels as oxygen sensors.
Circ. Res., 2000 Mar 17 , 86 (534-40).

585

Caballero R et al. Losartan and its metabolite E3174 modify cardiac delayed rectifier K(+) currents.
Circulation, 2000 Mar 14 , 101 (1199-205).

587

Dobrzynski H et al. Presence of the Kv1.5 K(+) channel in the sinoatrial node.
J. Histochem. Cytochem., 2000 Jun , 48 (769-80).

588

Grammer JB et al. Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation.
J. Cardiovasc. Electrophysiol., 2000 Jun , 11 (626-33).

589

Zhang TT et al. TRH regulates Kv1.5 gene expression through a Galphaq-mediated PLC-independent pathway.
Mol. Cell. Endocrinol., 2000 Jul 25 , 165 (33-9).

591

Rolf S et al. Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes.
Naunyn Schmiedebergs Arch. Pharmacol., 2000 Jul , 362 (22-31).

592

Hershman KM et al. RPTPmu and protein tyrosine phosphorylation regulate K(+) channel mRNA expression in adult cardiac myocytes.
Am. J. Physiol., Cell Physiol., 2000 Feb , 278 (C397-403).

593

Bou-Abboud E et al. Molecular diversity of the repolarizing voltage-gated K+ currents in mouse atrial cells.
J. Physiol. (Lond.), 2000 Dec 1 , 529 Pt 2 (345-58).

594

Ojamaa K et al. Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat.
Am. J. Physiol. Endocrinol. Metab., 2000 Dec , 279 (E1319-24).

595

596

Zhabyeyev P et al. Low-affinity block of cardiac K(+) currents by nifedipine.
Eur. J. Pharmacol., 2000 Aug 4 , 401 (137-43).

602

604

Peretz A et al. Tyrosine kinases modulate K+ channel gating in mouse Schwann cells.
J. Physiol. (Lond.), 1999 Sep 1 , 519 Pt 2 (373-84).

608

609

610

612

Vigdor-Alboim S et al. Discoordinate regulation of different K channels in cultured rat skeletal muscle by nerve growth factor.
J. Neurosci. Res., 1999 May 1 , 56 (275-83).

614

615

616

Fedida D et al. Modulation of slow inactivation in human cardiac Kv1.5 channels by extra- and intracellular permeant cations.
J. Physiol. (Lond.), 1999 Mar 1 , 515 ( Pt 2) (315-29).

617

Wang Z et al. Gating current studies reveal both intra- and extracellular cation modulation of K+ channel deactivation.
J. Physiol. (Lond.), 1999 Mar 1 , 515 ( Pt 2) (331-9).

618

Sheikh KA et al. The distribution of ganglioside-like moieties in peripheral nerves.
Brain, 1999 Mar , 122 ( Pt 3) (449-60).

619

Bou-Abboud E et al. Molecular correlates of the calcium-independent, depolarization-activated K+ currents in rat atrial myocytes.
J. Physiol. (Lond.), 1999 Jun 1 , 517 ( Pt 2) (407-20).

621

Po SS et al. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
J. Cardiovasc. Pharmacol., 1999 Feb , 33 (181-5).

622

Waldron GJ et al. Activation of vascular smooth muscle K+ channels by endothelium-derived relaxing factors.
Clin. Exp. Pharmacol. Physiol., 1999 Feb , 26 (180-4).

623

Kotecha SA et al. A Kv1.5 to Kv1.3 switch in endogenous hippocampal microglia and a role in proliferation.
J. Neurosci., 1999 Dec 15 , 19 (10680-93).

626

628

Delpón E et al. Blockade of cardiac potassium and other channels by antihistamines.
, 1999 , 21 Suppl 1 (11-8; discussion 81-7).

634

Franqueza L et al. Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels.
Br. J. Pharmacol., 1998 Nov , 125 (969-78).

635

636

Wible BA et al. Cloning and expression of a novel K+ channel regulatory protein, KChAP.
J. Biol. Chem., 1998 May 8 , 273 (11745-51).

641

648

Leicher T et al. Coexpression of the KCNA3B gene product with Kv1.5 leads to a novel A-type potassium channel.
J. Biol. Chem., 1998 Dec 25 , 273 (35095-101).

650

Jou I et al. Expression of Kv1.5 K+ channels in activated microglia in vivo.
Glia, 1998 Dec , 24 (408-14).

653

Dumaine R et al. Blockade of HERG and Kv1.5 by ketoconazole.
J. Pharmacol. Exp. Ther., 1998 Aug , 286 (727-35).

655

Abe A et al. Thyroid hormone regulates expression of shaker-related potassium channel mRNA in rat heart.
Biochem. Biophys. Res. Commun., 1998 Apr 7 , 245 (226-30).

658

Salter KJ et al. Endothelin-1, delayed rectifier K channels, and pulmonary arterial smooth muscle.
J. Cardiovasc. Pharmacol., 1998 , 31 Suppl 1 (S81-3).

659

Höllerer-Beitz G et al. Influence of detergents on the function of cloned potassium channels.
Recept. Channels, 1998 , 5 (61-78).

660

Suessbrich H et al. Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241.
FEBS Lett., 1997 Sep 8 , 414 (435-8).

663

Accili EA et al. Separable Kvbeta subunit domains alter expression and gating of potassium channels.
J. Biol. Chem., 1997 Oct 10 , 272 (25824-31).

666

671

672

Valenzuela C et al. Effects of ropivacaine on a potassium channel (hKv1.5) cloned from human ventricle.
Anesthesiology, 1997 Mar , 86 (718-28).

675

Zhang X et al. Characterization of nifedipine block of the human heart delayed rectifier, hKv1.5.
J. Pharmacol. Exp. Ther., 1997 Jun , 281 (1247-56).

676

Rampe D et al. Blockade of the human cardiac K+ channel Kv1.5 by the antibiotic erythromycin.
Naunyn Schmiedebergs Arch. Pharmacol., 1997 Jun , 355 (743-50).

677

Guo W et al. IGF-I regulates K(+)-channel expression of cultured neonatal rat ventricular myocytes.
Am. J. Physiol., 1997 Jun , 272 (H2599-606).

678

De Biasi M et al. Open channel block of human heart hKv1.5 by the beta-subunit hKv beta 1.2.
Am. J. Physiol., 1997 Jun , 272 (H2932-41).

679

Kodama I et al. Cellular electropharmacology of amiodarone.
Cardiovasc. Res., 1997 Jul , 35 (13-29).

683

Franqueza L et al. Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels.
Circ. Res., 1997 Dec , 81 (1053-64).

684

Nishiyama A et al. Effects of thyroid and glucocorticoid hormones on Kv1.5 potassium channel gene expression in the rat left ventricle.
Biochem. Biophys. Res. Commun., 1997 Aug 28 , 237 (521-6).

685

686

691

Matus-Leibovitch N et al. Chronic morphine administration enhances the expression of Kv1.5 and Kv1.6 voltage-gated K+ channels in rat spinal cord.
Brain Res. Mol. Brain Res., 1996 Sep 1 , 40 (261-70).

692

695

Wang Z et al. Comparison of binding and block produced by alternatively spliced Kvbeta1 subunits.
J. Biol. Chem., 1996 Nov 8 , 271 (28311-7).

696

Takimoto K et al. Altered K+ channel subunit composition following hormone induction of Kv1.5 gene expression.
Biochemistry, 1996 Nov 12 , 35 (14149-56).

699

701

Heinemann SH et al. Functional characterization of Kv channel beta-subunits from rat brain.
J. Physiol. (Lond.), 1996 Jun 15 , 493 ( Pt 3) (625-33).

703

Lee TE et al. N-type inactivation in the mammalian Shaker K+ channel Kv1.4.
J. Membr. Biol., 1996 Jun , 151 (225-35).

705

Fedida D et al. Slow gating charge immobilization in the human potassium channel Kv1.5 and its prevention by 4-aminopyridine.
J. Physiol. (Lond.), 1996 Jul 15 , 494 ( Pt 2) (377-87).

708

710

712

Scherer SS Molecular specializations at nodes and paranodes in peripheral nerve.
Microsc. Res. Tech., 1996 Aug 1 , 34 (452-61).

713

Bertoli A et al. Accumulation of long-lasting inactivation in rat brain K(+)-channels.
, 1996 Aug , 110 (401-12).

721

Bouchard R et al. Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5.
J. Pharmacol. Exp. Ther., 1995 Nov , 275 (864-76).

722

726

Chung S et al. Elimination of potassium channel expression by antisense oligonucleotides in a pituitary cell line.
Proc. Natl. Acad. Sci. U.S.A., 1995 Jun 20 , 92 (5955-9).

727

England SK et al. Characterization of a voltage-gated K+ channel beta subunit expressed in human heart.
Proc. Natl. Acad. Sci. U.S.A., 1995 Jul 3 , 92 (6309-13).

728

Korn SJ et al. Permeation selectivity by competition in a delayed rectifier potassium channel.
Science, 1995 Jul 21 , 269 (410-2).

729

Mays DJ et al. Localization of the Kv1.5 K+ channel protein in explanted cardiac tissue.
J. Clin. Invest., 1995 Jul , 96 (282-92).

734

Malayev AA et al. Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel.
Mol. Pharmacol., 1995 Jan , 47 (198-205).

735

736

Duprat F et al. Susceptibility of cloned K+ channels to reactive oxygen species.
Proc. Natl. Acad. Sci. U.S.A., 1995 Dec 5 , 92 (11796-800).

737

England SK et al. A novel K+ channel beta-subunit (hKv beta 1.3) is produced via alternative mRNA splicing.
J. Biol. Chem., 1995 Dec 1 , 270 (28531-4).

742

744

745

Valenzuela C et al. Effects of lisinopril on cardiac contractility and ionic currents.
Gen. Pharmacol., 1994 Sep , 25 (825-32).

748

Honore E et al. External blockade of the major cardiac delayed-rectifier K+ channel (Kv1.5) by polyunsaturated fatty acids.
Proc. Natl. Acad. Sci. U.S.A., 1994 Mar 1 , 91 (1937-41).

749

Lee TE et al. Structural determinant for assembly of mammalian K+ channels.
Biophys. J., 1994 Mar , 66 (667-73).

750

Timpe LC et al. Modulation of a voltage-activated potassium channel by peptide growth factor receptors.
J. Neurosci., 1994 Mar , 14 (1195-201).

754

755

758

Phromchotikul T et al. Dinucleotide repeat polymorphism at the KCNA5 locus.
Hum. Mol. Genet., 1993 Sep , 2 (1512).

762

Harrison NL et al. Modulation of gating of cloned rat and human K+ channels by micromolar Zn2+.
Mol. Pharmacol., 1993 Mar , 43 (482-6).

769